Table 2.
Baseline characteristics of study patients
| Patients for primary analysis (n = 4457) | |
|---|---|
| Age (years), mean (SD) | 60 (17) |
| Female, n (%) | 2065 (46) |
| Length of at‐risk period (days), median (IQR) | 190 (106–360) |
| DVT only, n (%) | 4022 (90) |
| DVT plus PE, n (%) | 435 (9·8) |
| Unprovoked DVT, n (%) | 2860 (64) |
| Previous VTE, n (%) | 1032 (23) |
| Active cancer, n (%) | 500 (11) |
| First available eGFR, n (%) | |
| <30 ml/min | 63 (1·4) |
| 30–50 ml/min | 224 (5·0) |
| ≥50 ml/min | 2569 (58) |
| Missing | 1601 (36) |
| Haemoglobin (g/l) | |
| Mean (SD) | 140 (17) |
| Missing, n (%) | 1731 (39) |
| Systolic blood pressure (mmHg) | |
| Mean (SD) | 137 (19) |
| Missing, n (%) | 2179 (49) |
| Previous major bleeding episode, n (%) | 91 (2·0) |
DVT, deep vein thrombosis; eGFR, estimated glomerular filtration rate; IQR, interquartile range; PE, pulmonary embolism.